NCT05234762View on ClinicalTrials.gov

Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

PHASE2UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 21, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Tremor, Essential
Interventions
DRUG

ES-481

Dose escalation during two Treatment Periods

OTHER

Placebo

Placebo dosed at same dosing as ES-481

Trial Locations (1)

Unknown

RECRUITING

Clinique Neuro-Levis, Lévis

Sponsors
All Listed Sponsors
lead

ES Therapeutics Australia Pty Ltd

INDUSTRY

NCT05234762 - Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors | Biotech Hunter | Biotech Hunter